Beermann, J., M. T. Piccoli, J. Viereck, and T. Thum. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325, 2016.
Burja, B., et al. Olive leaf extract attenuates inflammatory activation and DNA damage in human arterial endothelial cells. Front Cardiovasc Med. 6:56, 2019.
Castelli, G., E. Pelosi, and U. Testa. Liver cancer: molecular characterization, clonal evolution and cancer stem cells. Cancers (Basel). 9:127, 2017.
Chen, H. Z., S. Y. Tsai, and G. Leone. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 9:785–797, 2009.
De Stefano, F., et al. Novel biomarkers in hepatocellular carcinoma. Dig. Liver Dis. 50:1115–1123, 2018.
Du, W. W., et al. A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy. Oncogene. 37:5829–5842, 2018.
Ertosun, M. G., F. Z. Hapil, and O. Osman-Nidai. E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 31:17–25, 2016.
Fang, W., et al. microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget. 8:13253–13263, 2017.
Fang, L., D. Kong, and W. Xu. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1. Biomed Pharmacother. 102:203–211, 2018.
Farra, R., et al. The role of the transcription factor E2F1 in hepatocellular carcinoma. Curr Drug Deliv. 14:272–281, 2017.
Forner, A., M. Reig, and J. Bruix. Hepatocellular carcinoma. Lancet. 391:1301–1314, 2018.
Global Burden of Disease Liver Cancer Collaboration, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 3(1683–1691):2017, 1990.
Gong, X., B. Xu, L. Zi, and X. Chen. miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1. Cancer Manag Res. 11:6615–6624, 2019.
Gu, Y., et al. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1. Oncol Rep. 40:1863–1874, 2018.
Hollern, D. P., et al. E2F1 drives breast cancer metastasis by regulating the target gene fgf13 and altering cell migration. Sci Rep. 9:10718, 2019.
Jin, L., C. Li, T. Liu, and L. Wang. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Hum Genomics. 14:24, 2020.
Li, Q., et al. Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma. Cancer Med. 9:6354–6366, 2020.
Liu, P., et al. LINC00852 promotes lung adenocarcinoma spinal metastasis by targeting S100A9. J Cancer. 9:4139–4149, 2018.
Pan, W., et al. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Mol Oncol. 13:2246–2258, 2019.
Schmitt, A. M., and H. Y. Chang. Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463, 2016.
Sia, D., A. Villanueva, S. L. Friedman, and J. M. Llovet. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 152:745–761, 2017.
Wang, Z., et al. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Lett. 588:915–921, 2014.
Wang, Y., et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 18:28, 2019.
Wang, L., et al. LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression. J Cell Biochem. 121:2500–2509, 2020.
Wu, Z., S. Zheng, and Q. Yu. The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol. 41:2389–2397, 2009.
Xu, T. P., et al. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis. Cell Death Dis. 8:e2837, 2017.
Zhang, Y., et al. Identification of potential prognostic long non-coding RNA biomarkers for predicting recurrence in patients with cervical cancer. Cancer Manag Res. 12:719–730, 2020.
Zheng, H., et al. MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells. Oncotarget. 6:27805–27815, 2015.
Zhou, X., et al. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma. Oncogene. 35:5078, 2016.
Zhou, W. B., et al. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer. Biochem Biophys Res Commun. 470:838–844, 2016.